<DOC>
	<DOCNO>NCT00500760</DOCNO>
	<brief_summary>The addition chemotherapy radiotherapy ( chemoradiation ) improve outcomes patient locally advance squamous cell carcinoma head neck additional improvement treatment regimens need . The study investigate addition target therapy ( panitumumab ) improve efficacy chemoradiation without add unmanageable toxicity .</brief_summary>
	<brief_title>Study Addition Panitumumab Chemoradiation Therapy Patients With Locally Advanced Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Confirmed diagnosis Stage III IVab ( M0 ) squamous cell carcinoma oral cavity , oropharynx , hypopharynx larynx Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 ( must well enough receive chemoradiation therapy ) You must least 18 year age Your test result must show kidney , liver blood cell work adequately , female , pregnant You must measurable disease Cancer nasopharynx , sinus , salivary gland skin History another cancer ( head neck ) unless treat curative intent evidence disease 3 year , exception nonmelanoma skin cancer situ cervical cancer Previous treatment antiendothelial growth factor receptor ( EGFr ) antibody therapy EGFr inhibitor Previous treatment head neck cancer , chemotherapy , surgery ( except nodal sample biopsy ) radiotherapy Clinically significant cardiovascular disease ( include myocardial infarction , unstable angina , symptomatic congestive heart failure , serious uncontrolled cardiac arrhythmia ) within one year join study Chronic obstructive pulmonary disease ( pneumonia respiratory decompensation ) result hospitalization within 6 month study screen History evidence interstitial lung disease ( e.g . pneumonitis pulmonary fibrosis ) Major surgery within 28 day screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Head Neck Cancer</keyword>
	<keyword>panitumumab</keyword>
</DOC>